Equibles does not estimate personal net worth.
Get an email with a short summary when Guardant Health, Inc. publishes a filing, an earnings call transcript or a press release.
Get GH alertsMike Bell is recorded as CFO at Guardant Health, Inc. (GH). Mike Bell has spoken on 19 earnings calls and 4 other investor events across 1 company, most recently for Guardant Health, Inc. on November 5, 2026. Guardant Health, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Guardant Health, Inc. includes AmirAli Talasaz (CEO and Board Member), Helmy Eltoukhy (CEO, Chairman and Board Member), Michael Bell (CFO) and 7 others.
“Turning to slide 23, I'll walk through our third quarter results, unless otherwise noted, growth rates are year over year. Third quarter revenue reached $361 million, up 36%.”
“I think we just talked about all of the great news on the volume growth, on the revenue growth year over year. So, no, it was just another very, very strong quarter from GARDEN, and, yeah, we were really pleased with Q2.”
“Turning to slide 20, I'll walk through our second quarter results, unless otherwise noted, growth rates year over year. Second quarter revenue reached $335 million, up 44%.”
“You know, our overall revenue growth was 48% a year over year. It's the fastest revenue growth we've seen for the last five years, of course, off a much bigger base.”
“Yeah, before we begin, please note the forward-looking statement disclosures on this slide.”
Diagnostics & Research · Healthcare
CFO
